1. Medtech Insight

Minute Insight: Abbott’s Libre 3 Breaks In To UK Market

 
• By Barnaby Pickering

The NHS will now pay for the Libre 3 system as part of its NHS Supply Chain Network.

Minute Insight
Abbott's FreeStyle Libre 3 • Source: Informa/Alamy

Abbott ’s FreeStyle Libre 3 continuous glucose monitoring system is now available to eligible patients in the UK thanks to its listing on the NHS Supply Chain Network, the company announced 15 March.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Minute Insights

More from Medtech Insight

Secretary Kennedy’s FDA Visit Included CDRH Stop, Speech Warning Of ‘Agency Capture’

 
• By Sue Sutter

HHS Secretary Robert F. Kennedy Jr. urged FDA staff to resist the “deep state” and “crony capitalism,” and focus on improving the health of America’s children. “You're not here to take orders,” he said and urged FDA staff to speak up if they see wrongdoing.

Execs On The Move: 31 March to 4 April 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medtech Strategy Must Be Priority, German Diagnostics Firms Tell Government

 
• By Ashley Yeo

Germany’s incoming coalition government has reacted positively to industry’s calls for a dedicated medtech strategy to boost economic growth. Faster digitization, lower energy costs and “IVDR 2.0” are also on the in vitro diagnostic industry’s agenda.